vimarsana.com

Page 6 - மாநாடு அழைப்பு திட்டமிடப்பட்ட News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Penn Virginia Provides Operational Update

Penn Virginia Provides Operational Update
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

Share: Conference Call Scheduled for 4:30 p.m. ET today Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies, today reported financial results for the fourth quarter and year ended December 31, 2020. The Company ended fiscal year 2020 with $260 million in cash and marketable securities, which is expected to fund operations until the end of 2022. Geron s vision is to be recognized as a leader in the treatment of hematologic malignancies by changing the course of these diseases and thereby improving and extending the lives of patients, said John A. Scarlett, M.D., Chairman and Chief Executive Officer. In 2020, we made important progress toward realizing that vision through two ongoing Phase 3 clinical trials, presentation of new data and analyses providing strong evidence of imetelstat s disease-modifying potential that differentiates imetelstat from

ELBIT : SCHEDULES FOURTH QUARTER AND FULL YEAR 2020 RESULTS RELEASE FOR MARCH 24, 2021

elbitsystems@gkir.com This press release may contain forward‑looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Israeli Securities Law, 1968) regarding Elbit Systems Ltd. and/or its subsidiaries (collectively the Company), to the extent such statements do not relate to historical or current facts. Forward-looking statements are based on management s current expectations, estimates, projections and assumptions about future events. Forward‑looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions about the Company, which are difficult to predict, including projections of the Company s future financial results, its anticipated growth strategies and anticipated trends in its bus

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.